223 related articles for article (PubMed ID: 33517895)
1. Long term disease burden post-transplantation: three decades of observations in 25 Hurler patients successfully treated with hematopoietic stem cell transplantation (HSCT).
Guffon N; Pettazzoni M; Pangaud N; Garin C; Lina-Granade G; Plault C; Mottolese C; Froissart R; Fouilhoux A
Orphanet J Rare Dis; 2021 Jan; 16(1):60. PubMed ID: 33517895
[TBL] [Abstract][Full Text] [Related]
2. Musculoskeletal manifestations in mucopolysaccharidosis type I (Hurler syndrome) following hematopoietic stem cell transplantation.
Schmidt M; Breyer S; Löbel U; Yarar S; Stücker R; Ullrich K; Müller I; Muschol N
Orphanet J Rare Dis; 2016 Jul; 11(1):93. PubMed ID: 27392569
[TBL] [Abstract][Full Text] [Related]
3. Quantifying medical manifestations in Hurler syndrome with the infant physical symptom score: associations with long-term physical and adaptive outcomes.
Ahmed A; Rudser K; King KE; Eisengart JB; Orchard PJ; Shapiro E; Whitley CB
Mol Genet Metab; 2022 May; 136(1):22-27. PubMed ID: 35304037
[TBL] [Abstract][Full Text] [Related]
4. Long-term outcomes of adaptive functions for children with mucopolysaccharidosis I (Hurler syndrome) treated with hematopoietic stem cell transplantation.
Bjoraker KJ; Delaney K; Peters C; Krivit W; Shapiro EG
J Dev Behav Pediatr; 2006 Aug; 27(4):290-6. PubMed ID: 16906003
[TBL] [Abstract][Full Text] [Related]
5. Progression of Hip Dysplasia in Mucopolysaccharidosis Type I Hurler After Successful Hematopoietic Stem Cell Transplantation.
Langereis EJ; den Os MM; Breen C; Jones SA; Knaven OC; Mercer J; Miller WP; Kelly PM; Kennedy J; Ketterl TG; O'Meara A; Orchard PJ; Lund TC; van Rijn RR; Sakkers RJ; White KK; Wijburg FA
J Bone Joint Surg Am; 2016 Mar; 98(5):386-95. PubMed ID: 26935461
[TBL] [Abstract][Full Text] [Related]
6. Incidence of Bloodstream Infections after Hematopoietic Stem Cell Transplantation for Hurler Syndrome.
Dunseath C; O'Connor G; Mahulkar S; Badia P; Koo J; Dandoy CE
Transplant Cell Ther; 2023 Nov; 29(11):707.e1-707.e4. PubMed ID: 37582469
[TBL] [Abstract][Full Text] [Related]
7. The evolution of pulmonary function in childhood onset Mucopolysaccharidosis type I.
Broomfield A; Sims J; Mercer J; Hensman P; Ghosh A; Tylee K; Stepien KM; Oldham A; Prathivadi Bhayankaram N; Wynn R; Wright NB; Jones SA; Wilkinson S
Mol Genet Metab; 2021 Feb; 132(2):94-99. PubMed ID: 32713717
[TBL] [Abstract][Full Text] [Related]
8. Early skeletal outcomes after hematopoietic stem and progenitor cell gene therapy for Hurler syndrome.
Consiglieri G; Tucci F; De Pellegrin M; Guerrini B; Cattoni A; Risca G; Scarparo S; Sarzana M; Pontesilli S; Mellone R; Gasperini S; Galimberti S; Silvani P; Filisetti C; Darin S; Forni G; Miglietta S; Santi L; Facchini M; Corti A; Fumagalli F; Cicalese MP; Calbi V; Migliavacca M; Barzaghi F; Ferrua F; Gallo V; Recupero S; Canarutto D; Doglio M; Tedesco L; Volpi N; Rovelli A; la Marca G; Valsecchi MG; Zancan S; Ciceri F; Naldini L; Baldoli C; Parini R; Gentner B; Aiuti A; Bernardo ME
Sci Transl Med; 2024 May; 16(745):eadi8214. PubMed ID: 38691622
[TBL] [Abstract][Full Text] [Related]
9. Long-term Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Juvenile Metachromatic Leukodystrophy Compared With Nontransplanted Control Patients.
Groeschel S; Kühl JS; Bley AE; Kehrer C; Weschke B; Döring M; Böhringer J; Schrum J; Santer R; Kohlschütter A; Krägeloh-Mann I; Müller I
JAMA Neurol; 2016 Sep; 73(9):1133-40. PubMed ID: 27400410
[TBL] [Abstract][Full Text] [Related]
10. Obstructive sleep apnea syndrome after hematopoietic stem cell transplantation in children with mucopolysaccharidosis type I.
Moreau J; Brassier A; Amaddeo A; Neven B; Caillaud C; Chabli A; Fernandez-Bolanos M; Olmo J; Valayannopoulos V; Fauroux B
Mol Genet Metab; 2015 Dec; 116(4):275-80. PubMed ID: 26602600
[TBL] [Abstract][Full Text] [Related]
11. Open issues in Mucopolysaccharidosis type I-Hurler.
Parini R; Deodato F; Di Rocco M; Lanino E; Locatelli F; Messina C; Rovelli A; Scarpa M
Orphanet J Rare Dis; 2017 Jun; 12(1):112. PubMed ID: 28619065
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcome of Hurler syndrome patients after hematopoietic cell transplantation: an international multicenter study.
Aldenhoven M; Wynn RF; Orchard PJ; O'Meara A; Veys P; Fischer A; Valayannopoulos V; Neven B; Rovelli A; Prasad VK; Tolar J; Allewelt H; Jones SA; Parini R; Renard M; Bordon V; Wulffraat NM; de Koning TJ; Shapiro EG; Kurtzberg J; Boelens JJ
Blood; 2015 Mar; 125(13):2164-72. PubMed ID: 25624320
[TBL] [Abstract][Full Text] [Related]
13. Outcome in six children with mucopolysaccharidosis type IH, Hurler syndrome, after haematopoietic stem cell transplantation (HSCT).
Malm G; Gustafsson B; Berglund G; Lindström M; Naess K; Borgström B; von Döbeln U; Ringdén O
Acta Paediatr; 2008 Aug; 97(8):1108-12. PubMed ID: 18452566
[TBL] [Abstract][Full Text] [Related]
14. The effect of haemopoietic stem cell transplantation on the ocular phenotype in mucopolysaccharidosis type I (Hurler).
Javed A; Aslam T; Jones SA; Mercer J; Tyler K; Church H; Ghosh A; Wynn R; Sornalingam K; Ashworth J
Acta Ophthalmol; 2018 Aug; 96(5):494-498. PubMed ID: 29240299
[TBL] [Abstract][Full Text] [Related]
15. The craniocervical junction following successful haematopoietic stem cell transplantation for mucopolysaccharidosis type I H (Hurler syndrome).
Miebach E; Church H; Cooper A; Mercer J; Tylee K; Wynn RF; Wraith JE
J Inherit Metab Dis; 2011 Jun; 34(3):755-61. PubMed ID: 21416193
[TBL] [Abstract][Full Text] [Related]
16. Progression of organ manifestations upon enzyme replacement therapy in a patient with mucopolysaccharidosis type I/Hurler.
Mercimek-Mahmutoglu S; Reilly C; Human D; Waters PJ; Stoeckler-Ipsiroglu S
World J Pediatr; 2009 Nov; 5(4):319-21. PubMed ID: 19911152
[TBL] [Abstract][Full Text] [Related]
17. Heparan sulfate inhibits hematopoietic stem and progenitor cell migration and engraftment in mucopolysaccharidosis I.
Watson HA; Holley RJ; Langford-Smith KJ; Wilkinson FL; van Kuppevelt TH; Wynn RF; Wraith JE; Merry CL; Bigger BW
J Biol Chem; 2014 Dec; 289(52):36194-203. PubMed ID: 25359774
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcomes after allogeneic hematopoietic stem cell transplantation for metachromatic leukodystrophy: the largest single-institution cohort report.
Boucher AA; Miller W; Shanley R; Ziegler R; Lund T; Raymond G; Orchard PJ
Orphanet J Rare Dis; 2015 Aug; 10():94. PubMed ID: 26245762
[TBL] [Abstract][Full Text] [Related]
19. Outcome of unrelated donor bone marrow transplantation in 40 children with Hurler syndrome.
Peters C; Balthazor M; Shapiro EG; King RJ; Kollman C; Hegland JD; Henslee-Downey J; Trigg ME; Cowan MJ; Sanders J; Bunin N; Weinstein H; Lenarsky C; Falk P; Harris R; Bowen T; Williams TE; Grayson GH; Warkentin P; Sender L; Cool VA; Crittenden M; Packman S; Kaplan P; Lockman LA; Anderson J; Krivit W; Dusenbery K; Wagner J
Blood; 1996 Jun; 87(11):4894-902. PubMed ID: 8639864
[TBL] [Abstract][Full Text] [Related]
20. Neurocognitive Trajectory of Boys Who Received a Hematopoietic Stem Cell Transplant at an Early Stage of Childhood Cerebral Adrenoleukodystrophy.
Pierpont EI; Eisengart JB; Shanley R; Nascene D; Raymond GV; Shapiro EG; Ziegler RS; Orchard PJ; Miller WP
JAMA Neurol; 2017 Jun; 74(6):710-717. PubMed ID: 28418523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
